Contact
searchSearch
HMP Global

July 2018 - First Report Managed Care

Viewpoint
Adding Real Value: How Specialty Pharmacies Deliver on Value-Based Care
07/20/2018
Brandon Tom, PharmD
For specialty pharmacies who are excelling at high-touch, white glove, patient care—now is the time to take these conversations forward and be the ones who bring together each of the spokes on the wheel, including biopharma partners, payers,...
For specialty pharmacies who are excelling at high-touch, white glove, patient care—now is the time to take these conversations forward and be the ones who bring together each of the spokes on the wheel, including biopharma partners, payers,...
For specialty pharmacies who are...
07/20/2018
First Report Managed Care
Managed Care Q&A
Impact of CAR-T on Management of Hematological Malignancies
07/20/2018
An interview with Russel J Spjut, PharmD, formulary management clinical pharmacist and consultant at Formulary Intel Consulting.
An interview with Russel J Spjut, PharmD, formulary management clinical pharmacist and consultant at Formulary Intel Consulting.
An interview with Russel J...
07/20/2018
First Report Managed Care
Formulary Frontlines®
PARP Inhibitors for Ovarian Cancer: Who and When, And Can We Afford It?
07/20/2018
Sarah M. Temkin, MD; Don S. Dizon, MD
Sarah M Temkin, MD, and Don Dizon, MD, discuss the benefits of PARP inhibitors for treating ovarian cancer and why effectiveness, toxicity, safety, and cost must be balanced for an individual patient to determine the right PARP inhibitor for...
Sarah M Temkin, MD, and Don Dizon, MD, discuss the benefits of PARP inhibitors for treating ovarian cancer and why effectiveness, toxicity, safety, and cost must be balanced for an individual patient to determine the right PARP inhibitor for...
Sarah M Temkin, MD, and Don...
07/20/2018
First Report Managed Care
Conference Insider
Value-Based Care Delivery Model Outcomes Data Show Varying Quality Improvement
07/19/2018
A systematic review of value-based health care delivery models in oncology care presented at the American Society of Clinical Oncology (ASCO) Annual Meeting found that reports of outcomes are often lacking and show varying degrees of quality...
A systematic review of value-based health care delivery models in oncology care presented at the American Society of Clinical Oncology (ASCO) Annual Meeting found that reports of outcomes are often lacking and show varying degrees of quality...
A systematic review of...
07/19/2018
First Report Managed Care
Conference Insider
Comparative Effectiveness Study Examines Safety, Efficacy of Biosimilar in Clinical Trial, Real-World Practice
07/19/2018
According to a presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat...
According to a presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat...
According to a presentation at...
07/19/2018
First Report Managed Care
Conference Insider
Telehealth For Ovarian Genetic Counseling Improves Utilization
07/19/2018
A study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting found that telehealth-based genetic counseling and mandatory discussion of genetic counseling referral at the time of treatment planning improved...
A study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting found that telehealth-based genetic counseling and mandatory discussion of genetic counseling referral at the time of treatment planning improved...
A study presented at the 2018...
07/19/2018
First Report Managed Care
Conference Insider
Significant Economic Burden Associated With Early Progression in Newly Diagnosed Myeloma
07/19/2018
A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma, according to a study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. 
A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma, according to a study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. 
A new study attempted to...
07/19/2018
First Report Managed Care
Conference Insider
Daily Text Message Reminders Improve Adherence to Allopurinol
07/19/2018
Daily text message reminders for patients with gout who were prescribed allopurinol significantly improved adherence and outcomes, according to research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018).
Daily text message reminders for patients with gout who were prescribed allopurinol significantly improved adherence and outcomes, according to research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018).
Daily text message reminders for...
07/19/2018
First Report Managed Care
Conference Insider
Long Term Study Shows Early, Intensive RA Intervention Valuable
07/19/2018
A 23-year follow-up study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that early, intensive rheumatoid arthritis (RA) intervention with combination therapy demonstrated long term benefits and reduced...
A 23-year follow-up study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that early, intensive rheumatoid arthritis (RA) intervention with combination therapy demonstrated long term benefits and reduced...
A 23-year follow-up study...
07/19/2018
First Report Managed Care
Conference Insider
Study Examines Additional Costs of Non-Medical Biosimilar Switching
07/19/2018
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) examined how non-medical switching from originator biologic products to biosimilar products could increase or neutralize costs due to increased resource...
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) examined how non-medical switching from originator biologic products to biosimilar products could increase or neutralize costs due to increased resource...
A study presented at the 2018...
07/19/2018
First Report Managed Care
Conference Insider
RA-Related Joint Replacements Halved Over 13-Year Period
07/19/2018
Recent research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that over the past decade joint replacement surgeries for rheumatoid arthritis (RA) have decreased significantly. 
Recent research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that over the past decade joint replacement surgeries for rheumatoid arthritis (RA) have decreased significantly. 
Recent research presented at the...
07/19/2018
First Report Managed Care
Conference Insider
Real-World Dose Tapering of Biologics Reduces RA Costs
07/19/2018
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that dose tapering of biologics was cost saving for the treatment of rheumatic diseases in a real-world setting.
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that dose tapering of biologics was cost saving for the treatment of rheumatic diseases in a real-world setting.
A study presented at the 2018...
07/19/2018
First Report Managed Care
Conference Insider
Real-World Dose Tapering of Biologics Reduces RA Costs
07/19/2018
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that dose tapering of biologics was cost saving for the treatment of rheumatic diseases in a real-world setting.
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that dose tapering of biologics was cost saving for the treatment of rheumatic diseases in a real-world setting.
A study presented at the 2018...
07/19/2018
First Report Managed Care
Third-Party Payment Assistance Programs: The Good, the Bad, and the Ugly
07/19/2018
Paul Nicolaus
As alternative methods for connecting low-income consumers with health insurance and care emerge and evolve, some stakeholders see the potential of third-party payment (TPP) programs while others raise concerns. Experts help sort out the...
As alternative methods for connecting low-income consumers with health insurance and care emerge and evolve, some stakeholders see the potential of third-party payment (TPP) programs while others raise concerns. Experts help sort out the...
As alternative methods for...
07/19/2018
First Report Managed Care
The Challenge of Privatizing VA Care
07/13/2018
Dean Celia
Everyone agrees on the simple notion of giving veterans the care they deserve, but getting there is not as straightforward. First Report Managed Care spoke with former VA secretary David Shulkin and others—including a physician who works on...
Everyone agrees on the simple notion of giving veterans the care they deserve, but getting there is not as straightforward. First Report Managed Care spoke with former VA secretary David Shulkin and others—including a physician who works on...
Everyone agrees on the simple...
07/13/2018
First Report Managed Care
News
The Promise of Oral Insulin: Improving Adherence and Impacting Diabetes Outcomes
07/11/2018
Mary Beth Nierengarten
In order to better understand how the introduction of oral insulin will impact managing patients with type 2 diabetes, we spoke with two diabetes experts about the need to improve treatment and the potential role of oral insulin to help...
In order to better understand how the introduction of oral insulin will impact managing patients with type 2 diabetes, we spoke with two diabetes experts about the need to improve treatment and the potential role of oral insulin to help...
In order to better understand...
07/11/2018
First Report Managed Care

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Subscribe to receive the latest updates in managed care!

First Report Managed Care Newsletter

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

July 2018 Volume 15 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use